Free Virtual Consultations. Corona Virus Related Cases Click Here.

Albert Charles Farrell Killed in Crash on State Route 371 Near State Route 74

Man Goes Down Embankment in Fatal Anza Accident

Anza, CA (April 15, 2020) – A man was killed in a motorcycle crash in Anza. The fatal accident occurred on the afternoon of April 15 on State Route 371.

Albert Charles Farrell, 79, from Palm Springs, was riding a Harley-Davidson Electra on westbound State Route 371. He lost control near State Route 74 and went down an embankment. He was ejected from the motorcycle and he died at the accident scene.

Our heartfelt condolences go out to the friends and loved ones of Albert Charles Farrell.



November 11, 2019

1 Killed in Crash on Interstate 805 Near Murray Ridge Road

Solo-Vehicle Accident in San Diego Causes Fatality...

February 18, 2020

1 Killed, 5 Injured in Semi Truck Crash on State Route 4 Near Tracy Boulevard

Mauricio Solorio Garcia Arrested for DUI in Fatal Stockton Accident...

December 17, 2019

1 Injured in Big Rig Crash on Highway 120 Near Highway 99

3 Vehicles Collide in Manteca Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post

May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.

May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.